# Food-effect Study of Ammoxetine Hydrochloride Enteric-coated Tablets

> **NCT07508501** · PHASE1 · COMPLETED · sponsor: **CSPC ZhongQi Pharmaceutical Technology Co., Ltd.** · enrollment: 14 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** Ammoxetine hydrochloride enteric-coated tablets
- **DRUG:** Ammoxetine hydrochloride enteric-coated tablets

## Key facts

- **NCT ID:** NCT07508501
- **Lead sponsor:** CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-08
- **Primary completion:** 2023-02-24
- **Final completion:** 2023-04-04
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2026-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07508501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07508501, "Food-effect Study of Ammoxetine Hydrochloride Enteric-coated Tablets". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07508501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*